CannabisDeals US has quickly become a prominent force in the US cannabis industry, recently earning the title of Best Cannabis Deals Platform 2025 from Global Health & Pharma (GHP). The recognition adds to earlier accolades, including honours from the 2023 Commercial Cannabis Awards and the UK-based Prestige Awards. The platform is credited with transforming cannabis commerce through technology, transparency, and consumer empowerment.
Founded with the mission to help people find affordable cannabis products, CannabisDeals US allows consumers to compare dispensaries, deals, and promotions nationwide. It serves both recreational and medical users, offering a growing database of dispensaries, verified promotions, and exclusive discounts. By linking consumers, clinics, and retailers, the platform has become a trusted hub for those seeking value and reliability.
Among its innovations are AI-powered deal recommendations that analyse pricing patterns and consumer preferences, real-time price tracking through dispensary integrations, scalable architecture to accommodate market growth, and data analytics that benefit dispensaries and clinics. A highlight is the Bud Concierge, an AI assistant that guides users through strains, product types, and deals tailored to their needs.
“Technology is the bridge between legalisation and true accessibility,” said Theo Valmis, founder of CannabisDeals US. “Cannabis is no longer just about access, it is about smart access. Consumers want reliable information, personalized recommendations, and price transparency. That is why we have introduced our AI-powered Bud Concierge, which guides users to the right strains, products, and deals for their needs.”
The platform also supports medical cannabis patients by working with clinics to streamline consultations and medical card access. This role has become increasingly important as cannabis regulations vary across states. “Fragmentation is the biggest challenge the cannabis industry faces in the U.S. right now,” Valmis explained. “Regulations differ from state to state, making it difficult for consumers to navigate. Our role is to simplify this complexity by creating a unified resource that brings clarity and savings to customers everywhere.”
CannabisDeals US has been recognised internationally as well. In 2023, it was named Best CBD Marketplace, UK, by GHP. The Prestige Awards praised its consumer-first design and adaptability for global audiences. Valmis reflected on these honours, saying: “These awards show that we are not just building a deals site, but a platform that genuinely impacts how people access cannabis affordably and responsibly.”
Looking ahead, the company plans to expand its coverage to more states, deepen integrations with dispensary systems, and enhance AI-driven personalisation. “We aim to be the definitive cannabis shopping platform in the US, trusted by consumers, dispensaries, and clinics alike,” Valmis said. “With AI and real-time data, we will transform how people discover, compare, and buy cannabis.”
As the US cannabis market is projected to grow by 30% in 2025, CannabisDeals US is positioned to play a leading role in making cannabis commerce more transparent and accessible. Through its blend of technology and consumer focus, it continues to shape how Americans approach cannabis shopping.
